[go: up one dir, main page]

MX2021009038A - Composiciones topicas de naproxeno en gel. - Google Patents

Composiciones topicas de naproxeno en gel.

Info

Publication number
MX2021009038A
MX2021009038A MX2021009038A MX2021009038A MX2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A MX 2021009038 A MX2021009038 A MX 2021009038A
Authority
MX
Mexico
Prior art keywords
naproxen
gel compositions
topical gel
topical
compositions
Prior art date
Application number
MX2021009038A
Other languages
English (en)
Inventor
Olufoyekemi Badejo
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of MX2021009038A publication Critical patent/MX2021009038A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente divulgación se relaciona en general con composiciones analgésicas tópicas que comprenden fármacos antiinflamatorios no esteroideos, y más específicamente con composiciones tópicas de naproxeno en gel en combinación con agentes neutralizantes selectos, que poseen por lo tanto propiedades mejoradas de permeación cutánea y de retención cutánea, así como también una estética mejorada tras la aplicación y el secado.
MX2021009038A 2019-01-29 2020-01-08 Composiciones topicas de naproxeno en gel. MX2021009038A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962798352P 2019-01-29 2019-01-29
PCT/US2020/012654 WO2020159676A1 (en) 2019-01-29 2020-01-08 Topical gel compositions of naproxen

Publications (1)

Publication Number Publication Date
MX2021009038A true MX2021009038A (es) 2021-08-16

Family

ID=69411579

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009038A MX2021009038A (es) 2019-01-29 2020-01-08 Composiciones topicas de naproxeno en gel.

Country Status (7)

Country Link
US (1) US12274683B2 (es)
EP (1) EP3917493B1 (es)
AU (1) AU2020216278B2 (es)
BR (1) BR112021012822A2 (es)
CA (1) CA3127881A1 (es)
MX (1) MX2021009038A (es)
WO (1) WO2020159676A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3239346A1 (en) * 2021-11-22 2023-05-25 Arizona Board Of Regents On Behalf Of Arizona State University Solutions and gels of one-dimensional metal oxides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915470D0 (pt) * 1969-03-24 1973-03-13 Syntex Corp Processo para preparar derivados de acido 2-(6'substituido 2'naftil)propionico e de seus sais
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
DE60024811T3 (de) * 1999-05-27 2010-01-07 Acusphere, Inc., Watertown Poröse arzneistoffmatrizen und deren herstellungsverfahren
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
US20110052679A1 (en) * 2009-08-25 2011-03-03 Pharmaceutics International, Inc. Solid naproxen concentrates and related dosage forms

Also Published As

Publication number Publication date
CA3127881A1 (en) 2020-08-06
BR112021012822A2 (pt) 2021-11-03
US12274683B2 (en) 2025-04-15
EP3917493B1 (en) 2025-11-05
AU2020216278B2 (en) 2025-09-04
EP3917493A1 (en) 2021-12-08
WO2020159676A1 (en) 2020-08-06
AU2020216278A1 (en) 2021-07-15
US20220160667A1 (en) 2022-05-26

Similar Documents

Publication Publication Date Title
EP4599848A3 (en) Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
BR112015027281A8 (pt) usos de uma população de nanocarreadores sintéticos que são fixados a imunossupressores e composição compreendendo a referida população de nanocarreadores
HK1198320A1 (zh) 含各種天然成分組合的皮膚護理組合物
MX2010004613A (es) Composicion topica.
HK1212251A1 (zh) 局部组合物及其使用方法
BR112018004644A2 (pt) processo para alisamento semipermanente e modelagem permanente do cabelo
BR112018012749A2 (pt) composições para higiene pessoal
PH12019502607A1 (en) Skin composition booster oil
EA201291295A1 (ru) Высокоувлажняющая высокодисперсная эмульсия
EP4574832A3 (en) Dantrolene prodrugs and methods of their use
BR112016007462A2 (pt) fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite
WO2018094023A3 (en) Cyclic dipeptides and wound healing
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
BR112015012960A2 (pt) gel oral para o alívio da dor de dente
SA518400042B1 (ar) مترافق من فيناستيريد مع ببتيد
WO2018105941A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
PH12019500345A1 (en) Conjugate of minoxidil and peptide
MX2021009038A (es) Composiciones topicas de naproxeno en gel.
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
AU2017259411A1 (en) Treating activated dermal conditions with agents that target energy metabolism
WO2014039860A3 (en) Compositions and methods for modulating dnmt1 inhibitor activity
BR112019001799A2 (pt) composições para cuidados pessoais, processo para preparar uma composição e método não terapêutico para reduzir ou prevenir inflamação
EA201692426A1 (ru) Комбинации зальтопрофена и миорелаксанта
MX2016004842A (es) Uso de un extracto vegetal para la prevencion y tratamiento de perdida de pelo.
CA2913885C (fr) Compositions cosmetiques ou dermatologiques associant du retinaldehyde et de l'oleamide de glycylglycine, et leurs utilisations en cosmetique ou dermatologie